Molecular Docking Study of Gingkgo biloba Compounds as Potential Inhibitors of SARS-CoV-2. (2022). SCRIPTA SCORE Scientific Medical Journal, 4(1), 30-43. https://doi.org/10.32734/scripta.v4i1.8399